Pluri (NASDAQ:PLUR) Shares Down 4.5% – Should You Sell?

Pluri Inc. (NASDAQ:PLUR)’s stock price fell 4.5% on Tuesday . The company traded as low as $5.06 and last traded at $5.09. 40,459 shares were traded during trading, an increase of 121% from the average session volume of 18,346 shares. The stock had previously closed at $5.33.

Pluri Price Performance

The company has a quick ratio of 5.90, a current ratio of 5.90 and a debt-to-equity ratio of 4.44. The stock’s 50-day simple moving average is $5.08 and its two-hundred day simple moving average is $5.39. The company has a market capitalization of $28.30 million, a price-to-earnings ratio of -0.84 and a beta of 1.64.

Pluri (NASDAQ:PLUR) last posted its quarterly earnings data on Wednesday, September 18th. The company reported ($2.98) earnings per share for the quarter. The company had revenue of $0.26 million for the quarter. Pluri had a negative return on equity of 917.18% and a negative net margin of 4,184.28%.

About Pluri

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.